da Vinci Lawsuit News: Rottenstein Law Group LLP Comments on Study Showing Increased Costs of Robot Surgery

The firm is currently offering da Vinci robot lawsuit evaluations to those who have suffered allegedly serious complications during robotic surgery procedures.

(PRWEB) December 30, 2013

At least one study shows that medical outcomes of using a da Vinci surgical robot are often the same despite the robot surgery’s significantly greater costs, according to research featured in the January 2014 edition of Obstetrics & Gynecology journal. The Rottenstein Law Group LLP, which maintains the da Vinci Surgical System Lawsuit Center at http://www.roboticsurgerylawsuitcenter.com, comments on the recently published study and notes how other studies have shown added side effects resulting from robot surgery.

The study, "Robotic Compared With Laparoscopic Sacrocolpopexy: A Randomized Controlled Trial," compared two different methods for performing surgery to treat pelvic organ prolapse in women: laparoscopic (the more common method) and robotic sacrocolpopexy. It found that the outcomes and complications were similar, but that the robotic surgery using devices such as the da Vinci incurred a greater expense.* This, the study said, was largely because of the expense of purchasing and maintaining the device.

This is not the only cost, however. There is also the potential cost to the patient’s well-being. In early December 2013, the U.S. Food and Drug Administration announced that da Vinci maker Intuitive Surgical had notified its customers of a malfunction during surgery that potentially put patients at risk, according to a Dec. 4 Bloomberg story.** Friction in one of the device’s arms would cause the tools to stall, the story said. In the first ten months of 2013, the FDA received nearly 4,000 adverse event reports, ranging from claims of injury to death, according to a Nov. 11 Businessweek article.***

“The potential risks associated with this type of surgery have been well-documented, and we hear about them often from those interested in receiving compensation for the harms they have suffered,” said Rochelle Rottenstein, principal of the Rottenstein Law Group LLP, which represents clients in da Vinci surgical robot lawsuits. “Even though this study focuses more on the financial risks for a medical facility, it does add to a growing body of evidence supporting claims about the overall risks associated with this new technology.”

The da Vinci system usually features four robotic arms with precision surgical tools and a camera, designed to seemingly allow a surgeon to perform procedures such as prostate removals and hysterectomies less invasively than in the past. However, the robot system has been found to cause potentially dangerous side effects, such as internal burns, nerve damage and lacerations, according to Bloomberg.

The Rottenstein Law Group LLP encourages those who believe that their da Vinci robotic surgery harmed them to visit the firm’s da Vinci lawsuits FAQ page for quick answers to their questions and to contact an attorney for a free consultation.

*journals.lww.com/greenjournal/Abstract/2014/01000/Robotic_Compared_With_Laparoscopic_Sacrocolpopexy_.3.aspx

**bloomberg.com/news/2013-12-04/intuitive-warns-surgeons-of-friction-with-robotic-surgical-arms.html

***businessweek.com/news/2013-11-11/intuitive-robot-surgery-incidents-add-to-call-for-more-training

About THE ROTTENSTEIN LAW GROUP LLP
The Rottenstein Law Group LLP is a New York-based firm that represents clients nationwide in mass tort actions. The firm was founded by Rochelle Rottenstein, who has more than two decades of experience as a lawyer, to represent clients hurt by defective medical devices and medications. (Attorney advertising. Prior results do not guarantee a similar outcome.)

Contact:
The Rottenstein Law Group LLP
Rochelle Rottenstein, Esq.
321 W. 44th Street
# 804
New York NY 10036
(212) 933-9500 (office phone)
(212) 933-9980 (facsimile)
rochelle (at) rotlaw (dot) com
plus.google.com/106070664376281033016

Intuitive Surgical asserts that it is fully committed to superior training opportunities for surgeons and surgical teams in the use of its products, but notes that it does not participate in determining when a surgeon is adequately prepared to operate using the da Vinci Surgical System.